Biogen Inc.

Pharmaceuticals
United States
Earnings Per Share Growth (%)24.01%
Cost of Goods Sold (US$ Millions)$1,240
Current Liabilities (US$ Millions)$2,578
Total Assets (US$ Millions)$6,700
Long Term Debt$6,522
Return on Equity32.82%
Revenue (US$ Millions)$10,764
Total Company Assets$19,505
Revenue Growth (%)10.93%
Net Income (US$ Millions)$3,547
Earnings Per Share (US$)$24.01
Total Equity (US$ Millions)$9,373
Profit Margin (%)32.95%
Debt To Equity Ratio (%)0.70%
Inventory Turnover$893